Resources

The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.

Showing 506 Results

US v. Caronia and CER Communications

A landmark appeals court ruling could open the door for the pharmaceutical industry to discuss information about comparative effectiveness research (CER) results, even when the data examines off…

Understanding Individual Treatment Effects

Next week, health care stakeholders will convene in Washington, DC, to explore the role and challenges of individual treatment effects, or heterogeneity, in developing treatment recommendations,…

Why Individual Patient Differences Matter

At the end of this month, a diverse group of health care stakeholders will convene at a public meeting in Washington, DC, to discuss one of the unintended consequences of comparative effectiveness…

Current Challenges in Comparative Effectiveness Research

The National Pharmaceutical Council sponsored a cluster of articles in the October 2012 issue of Health Affairs, "Current Challenges in Comparative Effectiveness Research," and a related briefing on…

Webinar: Role of Pharmaceuticals in the ACO Environment

The National Pharmaceutical Council invites you to participate in an Advisor Live webinar, "The role of pharmaceuticals in the accountable care organization (ACO) environment." Advisor Live is a…

A Look at the CER Communications Landscape

The digital landscape has opened the door for a variety of stakeholders to share comparative effectiveness research (CER) online, but it’s not always easy to gauge the quality of the information…